ClinicalTrials.Veeva

Menu

Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment

Montefiore Medicine Academic Health System logo

Montefiore Medicine Academic Health System

Status and phase

Terminated
Phase 4

Conditions

Acute Pain

Treatments

Drug: Dsuvia

Study type

Interventional

Funder types

Other

Identifiers

NCT04716413
2021-12649

Details and patient eligibility

About

In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.

Enrollment

3 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age range 18-100 years
  • Currently taking Suboxone
  • ASA (American Society of Anesthesiology) physical score 1-3
  • Able to provide a signed informed consent
  • General anesthesia (either endotracheal intubation or laryngeal mask airway) or MAC (monitored anesthesia care) without the use of regional anesthesia

Exclusion criteria

  • Known allergic reactions to Dsuvia and its excipients
  • Severe respiratory illness including exacerbation of asthma attack
  • Significant intraoperative hemodynamic instability
  • Use of Regional anesthesia techniques

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3 participants in 2 patient groups

Treatment
Experimental group
Description:
Subjects will receive dose of Dsuvia 30mcg SL (1st dose) after induction but before first incision. Post-operatively, if subject rates pain higher than 4 out of 10, subject will receive a second dose of Dsuvia 30mcg SL (sublingual). If 30 minutes after second dose, subject rates pain higher than 4 out of 10, subject will receive ibuprofen 800mg IV. If 60 minutes after second dose, subject rates pain higher than 7 out of 10, subject will receive hydromorphone 0.4 mg IV.
Treatment:
Drug: Dsuvia
Control
No Intervention group
Description:
Subjects will be receive routine standard of care.

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Naum Shaparin, MD; Singh Nair, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems